Therapeutic Potential of Targeting the SUMO Pathway in Cancer

SIMPLE SUMMARY: The small ubiquitin-like modifier (SUMO) pathway regulates the hallmark properties of cancer cells. Moreover, alterations in activity and in levels of SUMO machinery components have been observed in human cancer. Due to the reversible nature of this post-translational protein modific...

Descripción completa

Detalles Bibliográficos
Autores principales: Kukkula, Antti, Ojala, Veera K., Mendez, Lourdes M., Sistonen, Lea, Elenius, Klaus, Sundvall, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431684/
https://www.ncbi.nlm.nih.gov/pubmed/34503213
http://dx.doi.org/10.3390/cancers13174402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431684/
https://www.ncbi.nlm.nih.gov/pubmed/34503213
http://dx.doi.org/10.3390/cancers13174402

Ejemplares similares